COVID Archive — Page 3 of 35

Stylized blue human face surrounded by numerous glowing orange, spiked spherical particles against a purple and black background.
February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.

Three-dimensional illustration of a coronavirus particle with a textured gray spherical surface, red spike proteins, and smaller yellow surface structures; blurred particles appear in the background.
January 26, 2023

Study to explore COVID’s impact on essential workers

Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.

Older man with white hair and glasses wearing a white medical coat and tie, smiling at the camera.
January 19, 2023

Emerging Infections Program lands national award for COVID response

Vanderbilt’s Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.

From left, Sean Collins, MD, MSc, Wesley Self, MD, MPH, Jessica Collins, program director, Vanderbilt Coordinating Center, and Matt Shotwell, PhD, play key roles in a now-international clinical trial platform that is investigating therapies aimed at reducing complications in patients hospitalized with COVID-19.
January 5, 2023

VUMC-led COVID-19 clinical trial platform goes international

The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.

Several syringes with orange safety caps arranged beside medical packaging and a partially visible label reading “COVID-19 Vaccine.”
January 4, 2023

VUMC strongly recommends COVID-19 bivalent booster vaccination as new COVID-19 variants appear in our region

With the development of new variants of the COVID-19 virus across the U.S. and the world, Vanderbilt University Medical Center recommends getting the bivalent booster vaccination.

Conceptual graphic combining a large clock face with coronavirus particle illustrations over dark storm clouds.
December 20, 2022

Reminder: COVID-19 bivalent boosters available through Occupational Health Clinic